References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; 2017 Available from: www.goldcopd.orgAccessed September 17, 2018
- AgustiAEdwardsLDCelliBECLIPSE InvestigatorsCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortEur Respir J201342363664623766334
- LawrencePJKolsumUGuptaVCharacteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patientsBMC Pulm Med20171714228219428
- VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- LeeJYChonGRRheeCKCharacteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team CohortJ Korean Med Sci201631455356027051239
- MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
- Ramírez-VenegasASansoresRHQuintana-CarrilloRHFEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposureAm J Respir Crit Care Med20141909996100225172140
- MeguroMBarleyEASpencerSJonesPWDevelopment and Validation of an Improved, COPD-Specific Version of the St. George Respiratory QuestionnaireChest2007132245646317646240
- MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
- WareJHDockeryDWLouisTAXuXPFerrisBGSpeizerFELongitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adultsAm J Epidemiol199013246857002403109
- FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
- SharmaGGoodwinJEffect of aging on respiratory system physiology and immunologyClin Interv Aging20061325326018046878
- SuzukiMMakitaHItoYMNagaiKKonnoSNishimuraMHokkaido COPD Cohort Study InvestigatorsClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
- GedebjergASzépligetiSKWackerhausenLHPrediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort studyLancet Respir Med20186320421229331311
- GoossensLMLeimerIMetzdorfNBeckerKRutten-van MölkenMPDoes the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trialBMC Pulm Med2014141416325326750
- KimJYoonHIOhYMLung function decline rates according to GOLD group in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101819182726379432